18-hydroxycorticosterone has been researched along with Autoimmune Demyelinating Disease, Peripheral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandstadter, R; Brody, J; Lublin, F; Morgello, S; Motiwala, R; Shin, S; Zhou, L | 1 |
1 other study(ies) available for 18-hydroxycorticosterone and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Primary Neurolymphomatosis Presenting With Polyradiculoneuropathy Affecting One Lower Limb.
Topics: 18-Hydroxycorticosterone; Antigens, CD20; bcl-Associated Death Protein; Combined Modality Therapy; Female; Functional Laterality; Humans; Immunologic Factors; Lower Extremity; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Peripheral Nervous System Neoplasms; Polyradiculoneuropathy; Positron-Emission Tomography | 2015 |